Yanez Michelle has filed 7 insider transactions across 3 companies since May 2023.
Most recent transaction: a grant/award of 50000 shares of Inhibitor Therapeutics, Inc. ($INTI) on April 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2025 | Inhibitor Therapeutics, Inc. | $INTI | Yanez Michelle | Director | A | Common Stock | 50000 | $0.00 | 896,271.0000 | 172,323,545 | 5.91% | 0.03% |
| Dec. 2, 2024 | Inhibitor Therapeutics, Inc. | $INTI | Yanez Michelle | Director | G | Common Stock | 250000 | $0.00 | 1,146,271.0000 | 0 | 27.89% | 0.00% |
| Dec. 9, 2024 | MIRA PHARMACEUTICALS, INC. | $MIRA | Yanez Michelle | Chief Financial Officer | A | Stock Options (right to buy) | 150000 | $0.00 | 150,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 27, 2024 | Telomir Pharmaceuticals, Inc. | $TELO | Yanez Michelle | Chief Financial Officer | A | Incentive Stock Options (right to buy) | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| April 1, 2024 | Inhibitor Therapeutics, Inc. | $INTI | Yanez Michelle | Director | A | Common Stock | 50000 | $0.00 | 896,271.0000 | 0 | 5.91% | 0.00% |
| March 26, 2024 | MIRA PHARMACEUTICALS, INC. | $MIRA | Yanez Michelle | Chief Financial Officer | A | Incentive Stock Option (right to buy) | 150000 | $0.00 | 57,799.0000 | 0 | 0.00% | 0.00% |
| May 5, 2023 | Inhibitor Therapeutics, Inc. | $INTI | Yanez Michelle | Director | J | Common Stock | 796271 | $0.00 | 800,673.0000 | 0 | 9999.99% | 0.00% |